Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Pender MP, Csurhes PA, Smith C, Douglas NL, Neller MA, Matthews KK, Beagley L, Rehan S, Crooks P, Hopkins TJ, Blum S, Green KA, Ioannides ZA, Swayne A, Aftab BT, Hooper KD, Burrows SR, Thompson KM, Coulthard A, Khanna R.
Pender MP, et al. Among authors: swayne a.
JCI Insight. 2018 Nov 15;3(22):e124714. doi: 10.1172/jci.insight.124714.
JCI Insight. 2018.
PMID: 30429369
Free PMC article.
Clinical Trial.